Filter
40
Filtered Results: 40
Text search:
Pfizer-
BioNTech
Comirnaty
Vaccine
Featured
Recommendations
7
Language
Document type
Guidelines
19
Fact sheets
10
Studies & Reports
5
Online Courses
3
Manuals
2
Strategic & Response Plan
1
Countries / Regions
Brazil
5
Ukraine
4
Russia
4
China
3
Germany
3
Middle East and North Africa
3
Mozambique
2
Argentina
2
Ecuador
2
Kazakhstan
1
Global
1
Western and Central Europe
1
Paraguay
1
Belarus
1
South Africa
1
Eastern Europe
1
Authors & Publishers
Publication Years
Category
COVID-19
18
Guidelines
9
Capacity Building
3
x MEDBOX Issue Brief & Annual Reports x
1
Vaccine-preventable Diseases
1
Policies
1
Women & Child Health
1
Information, Education and Communication (IEC)
1
Studies & Reports
1
Humanitarian Crisis
1
Pharmacy & Technologies
1
Toolboxes
Biontech/Pfizer Comirnaty
16
Country specific documents
9
Immunization Guidelines
6
Logistics & Supply
5
Access & Strategy
4
COVID-19 Vaccination
4
Online Courses & Resources
3
For Health Worker
3
COVID-19 Vaccination Information
3
mRna Vaccines general
3
Booster Doses
3
Communication Material
2
SARS-CoV-2 Variants
2
Vaccination
1
Pediatrics
1
Anamnesis / Screening
1
Infection Control General
1
For General Public & Community
1
For Parents & Children
1
Vaccination & Strategy
1
Videos
1
Vaccine Candidates & Research
1
Dashboards & Resource Platforms
1
Long COVID/ Post-COVID Syndrome
1
Moderna
1
Vector-based Vacines General
1
Vaxzevria (Astra Zeneca)
1
Johnson & Johnson
1
Research & Pipeline
1
Inactivated COVID-19 Vaccines
1
Essential Medicines
1
Prices and Patents
1
Situation Reports & Updates
1
Global Overview
1
Human Rights & the Right to Health
1
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan...
This document aims to provide guidance to healthcare facilities and healthcare providers in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) on preparedness and infection prevention and control (IPC) measures for the management of possible and confirmed cases of COVID-1...
COVID-19 & Vaccination
recommended
Issue Brief no.8. January 18,2021
Vaccination against the spread of the SARS-CoV-2 virus represents a milestone in the fight against the pandemic. Good communication and education of the population is essential for the success of the vaccination. Below is some information on vaccination strategies,...
Weekly epidemiological update on COVID-19, 28 September 2022
Diese Faktenboxen sollen Ihnen helfen, Nutzen und Schaden einer Schutzimpfung gegen COVID-19 abzuwägen. Die Informationen und Zahlen stellen keine endgültige Bewertung dar. Sie basieren auf den derzeit besten wissenschaftlichen Erkenntnissen.
Many critical questions remain about the effectiveness of COVID-19 vaccines in real-world settings. These questions can only be answered in post-introduction vaccine effectiveness studies.This guidance document outlines an approach to leverage existing surveillance systems for Severe Acute Respirato...
Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfemp...
24 May 2021; Guidance for vaccinators on how to store, prepare, draw up and administer COVID-19 vaccines Updated May 2021 · Western Cape Edition
Practical Approach to Care Kit: Vaccine
National Operationalisation Plan for the COVID-19 Vaccine : 13th edition
Esta orientação provisória foi desenvolvida com base na recomendação emitida pelo Grupo Consultivo Estratégico de Especialistas (SAGE) em imunização, em sua reunião extraordinária de 5 de janeiro de 2021, e atualizada durante sua reunião extraordinária de 27 de maio de 2021 (2), sendo no...
5 April 2022, Addendum. This policy brief confirms WHO guidance and policy on injection safety in the context of the extraordinary increase in global injections resulting from COVID-19 immunization campaigns. It also calls attention to information on specialized syringes for COVID-19 vaccines and br...
Dispõe sobre orientações para identificação, investigação e manejo do evento adverso pós vacinação de miocardite/pericardite no contexto da vacinação contra a COVID-19 no Brasil
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
Guidelines for the Vaccination Scheme against
COVID 19: Booster Dose Health Personnel
Guidelines for the Vaccination Plan against COVID-19 in children 5 to 11 years, 11 months, 29 days with COVID-19 Vaccine Coronovac / Sinovac
A rapid evidence briefing. Vaccinated people are less likely to develop long COVID, even if they get infected, a rapid review of 15 studies by the UK Health Security Agency shows.
O SAGE aplica os princípios da medicina baseada em evidências e estabeleceu um processo metodológico completo para emitir ou atualizar recomendações. Especificamente para vacinas contra a COVID-19, uma descrição detalhada dos processos metodológicos pode ser encontrada no esquema de evidênc...
(Last Update: July 2022)
La miocarditis es una enfermedad inflamatoria con compromiso focal o difuso del miocardio, que se presenta de forma fulminante, pudiendo ser aguda, subaguda o crónica.Las que poseen un nivel de gravedad suficiente para reconocerlas clínicamente, son raras, pero la prevalencia de los casos leves y ...
